文献速递糖尿病

2000-2015年全球糖尿病相关终末期肾病流行病学

Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000-2015.
PubMed 文献 · Diabetes Care · 2020-11-17

本研究基于142个国家数据(覆盖全球97.3%人口),估算2000-2015年糖尿病患者中终末期肾病(ESRD)的年度发病率。全球糖尿病患者ESRD年发病率从375.8/百万糖尿病患者升至1016.0/百万,流行ESRD中糖尿病占比从19.0%升至29.7%,发病ESRD中糖尿病占比从22.1%升至31.3%,西太平洋地区平均率最高。

要点

  • 全球糖尿病患者ESRD年发病率2000-2015年从375.8升至1016.0/百万糖尿病。
  • 流行ESRD中糖尿病占比从19.0%升至29.7%,发病ESRD中从22.1%升至31.3%。
  • 西太平洋地区平均率最高,欧洲为西太平洋的1/2至1/3。

核心结论

  • 糖尿病患者进展至ESRD的年率存在巨大且非随机的地区差异,提示医疗、环境和/或遗传因素影响糖尿病肾病进展。
  • 预防和治疗糖尿病相关ESRD需要更好的患者易感性分层。

研究设计与样本

  • 全球性观察研究,数据来自142个国家,覆盖97.3%的世界人口。
  • 糖尿病患者ESRD年发病率计算为:新发ESRD伴糖尿病患者数除以糖尿病患者总数减去已患ESRD人数后的商。
  • ESRD患病率和年发病率分别用德国费森尤斯医疗提供的数据和既往报告数据验证。

主要发现

  • 全球流行ESRD患者中糖尿病占比从2000年19.0%升至2015年29.7%。
  • 全球发病ESRD患者中糖尿病占比从2000年22.1%升至2015年31.3%。
  • 全球糖尿病患者ESRD年发病率从2000年375.8/百万糖尿病升至2015年1016.0/百万糖尿病。
  • 西太平洋地区平均率最高;2000-2015年欧洲糖尿病患者ESRD发病率范围为西太平洋人群的1/2(309.2 vs. 544.6)至1/3(419.4 vs. 1245.2)。

临床怎么用

  • 应关注糖尿病患者ESRD发病率的地区差异,针对高危人群加强筛查和干预。
  • 需开展患者易感性分层以优化糖尿病相关ESRD的预防和治疗措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The annual risk among patients with diabetes of reaching end-stage renal disease (ESRD) is largely unknown worldwide. This study aimed to compare the incidence of diabetes-related ESRD by creating a global atlas during 2000-2015. RESEARCH DESIGN AND METHODS: The annual incidence of ESRD among patients with diabetes was calculated as the quotient of the number of incident ESRD patients with diabetes divided by the total number of patients with diabetes after subtraction of the number with existing ESRD. The estimated ESRD prevalence and annual incidence were validated with use of the data provided by Fresenius Medical Care, Germany, and previously reported data, respectively. RESULTS: Data were obtained from 142 countries, covering 97.3% of the world population. The global percentage of the prevalent ESRD patients with diabetes increased from 19.0% in 2000 to 29.7% in 2015 worldwide, while the percentage of incident ESRD patients due to diabetes increased from 22.1% to 31.3%. The global annual incidence of ESRD among patients with diabetes increased from 375.8 to 1,016.0/million with diabetes during 2000-2015. The highest average rates were observed in the Western Pacific Region. Comparatively, the rates of incident ESRD among European patients with diabetes ranged from one-half (309.2 vs. 544.6) to one-third (419.4 vs. 1,245.2) of the rates of the Western Pacific population during 2000-2015. CONCLUSIONS: Great and nonrandom geographic variation in the annual rates among patients with diabetes of reaching ESRD suggests that distinct health care, environmental, and/or genetic factors contribute to the progression of diabetic kidney disease. Measures to prevent and treat diabetes-related ESRD require better patient susceptibility stratification.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Cheng HT, Xu X, Lim PS, et al. Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000-2015. Diabetes Care. 2020. PMID: 33203706. doi:10.2337/dc20-1913

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。